SEC Form 4 · accession 0001214659-16-013774
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul F Truex
Officer — Chief Executive Officer
Period of report
Sep 20, 2016
Accepted (ET)
Sep 22, 2016 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Sep 20, 2016 | M | 5,008 | $2.08 | A | 5,008 | D | |
| Common stock | Sep 20, 2016 | G | 5,008 | $0.00 | D | 0 | D | |
| Common stock | Sep 20, 2016 | G | 5,008 | $0.00 | A | 94,345 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $2.08 | Jan 23, 2007 | M | 5,008 | D | — | Jan 23, 2017 | Common Stock | 5,008 | 25,845 | D |
Explanation of responses
- F1On September 20, 2016, the reporting person transferred 5,008 shares to the 2005 Truex Family Trust u/d/t April 20, 2005
- F2The stock option vests and becomes exercisable in 48 equal monthly installments from the vesting commencement date of October 3, 2005. This stock option was fully exercisable on October 3, 2009.